These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection]. Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752 [TBL] [Abstract][Full Text] [Related]
9. [Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis]. Hirose T; Yoshiaki K; Yokoo A; Umehara T; Miyake M; Takatsuka K; Sato T; Miyamoto S; Tanaka N; Miyao N Kansenshogaku Zasshi; 1992 Oct; 66(10):1462-72. PubMed ID: 1338088 [TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections]. Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562 [TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of tosufloxacin against fresh clinical isolates]. Yamashiro Y; Shimakura M; Minami S; Fukuoka Y; Yasuda T; Watanabe Y; Narita H; Akama M Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895 [TBL] [Abstract][Full Text] [Related]
12. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents. Barry AL; Jones RN J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259 [TBL] [Abstract][Full Text] [Related]
13. Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations. Del Río G; Dalet F; Aguilar L; Caffaratti J; Dal-Ré R Antimicrob Agents Chemother; 1996 Feb; 40(2):408-12. PubMed ID: 8834888 [TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of tosufloxacin against recently obtained clinical isolates]. Ishihara R; Suzuki Y; Tanaka S; Fukayama S; Deguchi K; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1996 Jul; 49(7):715-42. PubMed ID: 8828073 [TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691 [TBL] [Abstract][Full Text] [Related]
16. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up. Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262). Yazawa K; Mikami Y; Uno J Antimicrob Agents Chemother; 1989 Dec; 33(12):2140-1. PubMed ID: 2619279 [TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. King A; Bethune L; Phillips I J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930 [TBL] [Abstract][Full Text] [Related]
19. Short-course therapy of acute cystitis: a brief review of therapeutic strategies. Tice AD J Antimicrob Chemother; 1999 Mar; 43 Suppl A():85-93. PubMed ID: 10225577 [TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988]. Suzuki K; Nagata Y Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]